Antimicrobial regime for cardiac surgery: The safety and effectiveness of short-course flucloxacillin (or teicoplanin) and gentamicin-based prophylaxis

Journal of Cardiac Surgery

Volumn 28, Issue 5, 2013, Pages 512-516

  White, Ralph W ^a   West, Robert ^b   Howard, Philip ^c   Sandoe, Jonathan ^c  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; CEPHALOSPORIN; CHLORHEXIDINE; FLUCLOXACILLIN; GENTAMICIN; POVIDONE; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART SURGERY; HEART VALVE REPLACEMENT; HEART VALVE SURGERY; HUMAN; INFECTION; INFECTION RISK; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHROTOXICITY; OUTCOMES RESEARCH; PENICILLIN ALLERGY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; REOPERATION; RETROSPECTIVE STUDY; RISK REDUCTION; SCORING SYSTEM; SINGLE DRUG DOSE; STERNOTOMY; SURGICAL INFECTION; TIME SERIES ANALYSIS; TREATMENT OUTCOME; WOUND INFECTION;

AGED; ANTIBIOTIC PROPHYLAXIS; CARDIAC SURGICAL PROCEDURES; CEFUROXIME; COHORT STUDIES; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; FLOXACILLIN; GENTAMICINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TEICOPLANIN;

EID: 84883882362     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/jocs.12155     Document Type: Article

References (17)

1. Hillis LD, Smith PK, Anderson JL, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2012; 143: 4-34.
2. Hollenbeak CS, Murphy DM, Koenig S, et al. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000; 118: 397-402.
3. Olsen MA, Lock-Buckley P, Hopkins D, et al. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg 2002; 124: 136-145.
4. Braxton JH, Marrin CA, McGrath PD, et al. 10-year follow-up of patients with and without mediastinitis. Semin Thorac Cardiovasc Surg 2004; 16: 70-76.
5. Wilson AP, Treasure T, Sturridge MF, et al. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet 1986; 1: 311-313.
6. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373-1379.
7. Baskett RJ, MacDougall CE, Ross DB:, Is mediastinitis a preventable complication? A 10-year review. Ann Thorac Surg 1999; 67: 462-465.
8. Crabtree TD, Codd JE, Fraser VJ, et al. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg 2004; 16: 53-61.
9. Trussell J, Gerkin R, Coates B, et al. Impact of a patient care pathway protocol on surgical site infection rates in cardiothoracic surgery patients. Am J Surg 2008; 196: 883-889.
10. Fakih MG, Sharma M, Khatib R, et al. Increase in the rate of sternal surgical site infection after coronary artery bypass graft: A marker of higher severity of illness. Infect Control Hosp Epidemiol 2007; 28: 655-660.
11. Society of Thoracic Surgeons. STS NCD Executive Summary, Spring, 2003.
12. SIGN. Antibiotic Prophylaxis in Surgery. Scottish Intercollegiate Guideline Network Publication Number 104. Edinburgh, 2008.
13. Leaper D, Burman-Roy S, Palanca A, et al. Guideline Development Group. Prevention, treatment of surgical site infection: Summary of NICE guidance. BMJ. 2008; 337: a1924.
14. Engelman R, Shahian D, Shemin R, et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, Part II: Antibiotic choice. Ann Thorac Surg 2007; 83: 1569-1576.
15. Edwards FH, Engelman RM, Houck P, et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, Part I: Duration. Ann Thorac Surg 2006; 81: 397-404.
16. Mastoraki S, Michalopoulos A, Kriaras I, et al. Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery. Interact Cardiovasc Thorac Surg 2007; 6: 442-446.
17. Oxman DA, Issa NC, Marty FM, et al. Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: A double-blind, placebo-controlled, randomized trial. JAMA Surg 2013; 148: 440-446.